Eculizumab therapy for atypical haemolytic uraemic syndrome due to a gain-of-function mutation of complement factor B.
about
Critical appraisal of eculizumab for atypical hemolytic uremic syndromeAdvances and challenges in the management of complement-mediated thrombotic microangiopathiesComplement therapy in atypical haemolytic uraemic syndrome (aHUS).Eculizumab in atypical haemolytic uraemic syndrome with severe cardiac and neurological involvement.Complement factor B mutations in atypical hemolytic uremic syndrome-disease-relevant or benign?Eculizumab therapy leads to rapid resolution of thrombocytopenia in atypical hemolytic uremic syndromeA complicated case of atypical hemolytic uremic syndrome with frequent relapses under eculizumab.Neonatal atypical hemolytic uremic syndrome from a factor H mutation treated with eculizumabAn international consensus approach to the management of atypical hemolytic uremic syndrome in children.Diabetic ketoacidosis presenting with atypical hemolytic uremic syndrome associated with a variant of complement factor B in an adult: a case report.Clinical Relapses of Atypical HUS on Eculizumab: Clinical Gap for Monitoring and Individualised Therapy.Hemolytic uremic syndrome
P2860
Q26750692-4F12C09F-7F31-4FA6-9EEA-260FBEE857CFQ26796453-8B01C08A-E4C5-4B6E-BC2A-8194F9E684BBQ33408733-7F2E7090-52BD-4FEF-A69A-DADE3B03D71BQ33411956-44A8BF7B-865D-4B16-BD73-C32170413F5EQ33414109-D256D58A-EBAC-471A-BB9B-06B2F91DD14AQ33418725-F51CD9A0-4FB6-47FE-8B39-D8E4EDA58D85Q33420998-75B0BB4F-D53E-46E6-BA20-30A0A585CF66Q33421504-4AB8D8BE-E4DC-41C9-AF4A-1A6CC99C5C6CQ33421861-963FB006-BBC1-4A9D-97B0-D48DFA1304FFQ33430267-81BE95CE-1705-4CDC-9120-65EF21B340BAQ52649557-2039F417-8B50-4158-8E97-F80C89E965D1Q57701679-826220C7-19E0-4B10-9E00-46B2164AFE08
P2860
Eculizumab therapy for atypical haemolytic uraemic syndrome due to a gain-of-function mutation of complement factor B.
description
2013 nî lūn-bûn
@nan
2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Eculizumab therapy for atypica ...... tation of complement factor B.
@ast
Eculizumab therapy for atypica ...... tation of complement factor B.
@en
type
label
Eculizumab therapy for atypica ...... tation of complement factor B.
@ast
Eculizumab therapy for atypica ...... tation of complement factor B.
@en
prefLabel
Eculizumab therapy for atypica ...... tation of complement factor B.
@ast
Eculizumab therapy for atypica ...... tation of complement factor B.
@en
P2093
P2860
P1433
P1476
Eculizumab therapy for atypica ...... tation of complement factor B.
@en
P2093
Darren J Fowler
Elizabeth Angus
Louise Stanley
Stephen A Hardy
Timothy H Goodship
P2860
P2888
P304
P356
10.1007/S00467-013-2492-X
P577
2013-04-28T00:00:00Z
P6179
1005262642